19/06/2026
Aotearoa New Zealand researchers and clinicians have contributed to a major international clinical trial that is set to change how Staphylococcus aureus bloodstream infections are treated worldwide
Read more
14/05/2026
CLINICAL LINK - ACTT’s quarterly update for our sponsors, partners and collaborators. Sharing key milestones, research activity, business growth, opportunities to engage, and the collective impact made possible through our work together.
Read more
14/05/2026
CRANZ Announcement | Gold-level Reaccreditation: IAOCR GSCA | NEJM Publication: Systemic Lupus Erythematosus | Whangārei: Research Day, 8th June | Middlemore: Celebrating Research, 29th October | Research Survey | Upcoming Trials | Recent Publications
Read more
24/04/2026
Strengthening our partnership with the PPD clinical research business of Thermo Fisher Scientific
Read more
11/12/2025
As the end of the year approaches, it is encouraging to reflect on ACTT’s strong performance across a broad range of therapeutic areas. Our involvement in cutting-edge research, including modern CRISPR therapies for rare diseases and inherited cholesterol disorders, and next generation of triple agonists in the metabolic space – continues to put Aotearoa on the map.
Read more
